Literature DB >> 10408423

Management of sexual side effects of antidepressant therapy.

R M Hirschfeld1.   

Abstract

Sexual dysfunction occurs in over one third of the general population and has many causes, including psychosocial factors, general medical illness, nonpsychiatric medication, psychiatric disorders, and psychotropic medications. Psychosocial causes are the most prevalent, but many frequently used medications, such as diuretics, beta-blockers, and H2-blockers, can also cause sexual dysfunction. Sexual dysfunctions occur in many psychiatric disorders, including mood disorders, schizophrenia, substance abuse, and anxiety disorders. In addition, over half the patients with major depression will have some sexual dysfunction. Although much attention has been paid to sexual dysfunction associated with the selective serotonin reuptake inhibitors (SSRIs), many other commonly used psychotropics are associated with a variety of sexual dysfunction, including haloperidol, benzodiazepines, stimulants, and drugs of abuse. With regard to SSRIs, sexual dysfunction occurs in 50% or more of such patients, which is substantially higher than the rates reported in the Physicians' Desk Reference. The reason for this discrepancy is that patients will not spontaneously report sexual problems and must be questioned about such problems directly. A variety of strategies exist to manage antidepressant-induced sexual dysfunction, including waiting, reducing the antidepressant dose, use of drug holidays, use of adjunctive pharmacotherapy, and switching antidepressants. Use of an antidepressant with a low prevalence of sexual side effects, such as bupropion, nefazodone, and mirtazapine, may also be considered.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408423

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  6 in total

1.  Treatment of Hypoactive Sexual Desire Disorder Among Women: General Considerations and Pharmacological Options.

Authors:  Gabriela S Pachano Pesantez; Anita H Clayton
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25

Review 2.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

3.  The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care.

Authors:  Robert M. A. Hirschfeld
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-12

4.  Acute caffeine reverses the disruptive effects of chronic fluoxetine on the sexual behavior of female and male rats.

Authors:  Brunella V González Cautela; Gonzalo R Quintana; Jessica Akerman; James G Pfaus
Journal:  Psychopharmacology (Berl)       Date:  2020-11-26       Impact factor: 4.530

5.  Targeting the Psychosexual Challenges Faced by Couples with Breast Cancer: Can Couples Group Psychotherapy Help?

Authors:  Luciana Lagana; Patricia Fobair; David Spiegel
Journal:  J Womens Health Care       Date:  2014-11-17

6.  Sexual dysfunction among female patients of reproductive age in a hospital setting in Nigeria.

Authors:  Benjamin A Fajewonyomi; Ernest O Orji; Adenike O Adeyemo
Journal:  J Health Popul Nutr       Date:  2007-03       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.